비교리스트

 카트 문의
시장보고서
상품코드
1464679

세계의 지방유래 줄기세포 시장 : 유형별, 제품별, 질환별, 기술별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Adipose Derived Stem Cell Market, By Type, By Product Type, By Disease, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 279 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 지방 유래 줄기세포(ADSC, Adipose Derived Stem Cell) 시장 규모는 2023년에 21억 4,450만 달러에 달했으며, 2024-2032년에 걸쳐 CAGR 14.5%로 확대될 것으로 예측되고 있습니다.

지방유래 줄기세포 시장-시장 역학

최소 침습 미용 성형에 대한 수요 증가가 시장 성장을 가속할 것으로 예측

지방 흡입은 ADSC 분리를 위해 지방 조직을 채취하는 데 일반적으로 사용되는 절차이며 ADSC 기반 치료를위한 지방 조직의 가용성에 기여합니다. 미국형성외과학회(ASPS)는 2018년 미국에서 약 1,800만 명이 수술적이고 침습적인 미용 성형 수술을 받았다고 보고했으며, 증가 추세를 보이고 있습니다. 이러한 시장의 성장은 ADSC를 기반으로 하는 제품과 치료법을 상용화하는 기업들에게도 기회를 제공합니다. 그러나 안전에 대한 우려가 시장 확대에 제약을 초래할 수 있다는 점에 주의해야 합니다.

지방유래 줄기세포 시장-주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 시장은 예측 기간(2024-2032년)에 CAGR 약 14.5%로 매년 성장할 것으로 예측되고 있습니다.

유형별로, 동종 줄기세포는 2023년에 가장 큰 시장 점유율을 나타낼 것으로 예측됩니다.

지역별로는 북미가 2023년 매출을 이끌고 있습니다.

지방유래 줄기세포 시장-세분화 분석 :

세계의 지방유래 줄기세포 시장은 유형, 제품, 질병, 기술, 지역에 따라 세분화됩니다.

시장은 유형에 따라 두 그룹으로 분류됩니다. 즉, 자가 줄기 세포와 동종 줄기 세포입니다. 동종 줄기 세포가 시장의 대부분을 차지하고 있습니다. 지방유래 줄기세포와 동종 줄기 세포의 조합은 재생 의학에서 중요한 연구 분야이며 진보입니다. 이러한 줄기세포공급원은 명확한 이점을 제공하고 있으며, 다양한 질병이나 병리학의 치료 가능성에 대해 현재 연구가 진행되고 있습니다.

시장은 제품에 따라 4개의 그룹으로 구분됩니다 : 세포주, 배양액, 배지, 혈청, 시약. 지방유래 줄기세포 시장에는 세포주, 배양액, 배지, 혈청, 시약 등 폭넓은 제품이 포함되어 있으며, 이들 모두 재생의료 분야에서의 연구개발 및 상업화의 추진에 필수적입니다.

시장은 질병별로 8가지 카테고리로 분류되어 있습니다 : 암, 비만, 상처·상해, 근골격계 질환, 심장혈관계 질환, 중추신경계 질환, 대사성 질환, 소화기계 질환, 기타 질환. 지방 유래 줄기세포는 범용성이 높고 재생능력을 가지기 때문에 폭넓은 의료 분야에서 혁신적인 치료법의 유망한 후보로 자리매김하고 있습니다.

이 시장은 최종 사용자별로 세포 은행, 조직 은행, 연구소, 학술 기관, 병원, 외상 센터 등으로 분류됩니다. 재생 의료 분야의 진보를 촉진하고 ADSC 기반 치료법의 임상 응용을 촉진하기 위해서는 이러한 이해 관계자의 협력과 학제 간 노력이 필수적입니다.

지방유래 줄기세포 시장-지리적 통찰

지역적으로 이 시장은 북미, 남미, 유럽, 아시아태평양, 중동 및 아프리카에 널리 퍼져 있습니다. 이 지역은 사업 활동을 하는 국가에 따라 더 분류됩니다. 시장은 주로 북미가 지배적이지만, 이는 주로 다양한 조직에 의한 연구개발 이니셔티브의 수가 증가하고 있기 때문입니다. 특히 미국 국립위생연구소(NIH)와 같은 북미 정부 기관은 줄기세포 연구에 엄청난 자금을 제공하는 데 중요한 역할을 합니다. 이 재정 지원은 연구 개발 노력을 크게 가속화하고 기술 혁신을 촉진하며 ADSC의 생물학적 이해와 치료 응용의 발전에 기여합니다. 2019년 미국은 연구개발(R&D)의 눈부신 실적을 목격하여 6,670억 달러에 달했지만, 전미과학재단의 보고에 따르면 2020년에는 더욱 증가해 7,080억 달러에 달할 것으로 추정 되었습니다. 유럽은 주로 재생의료에 대한 소비자의 의식이 높아짐에 따라 시장 성장에서 2위를 차지하고 있습니다.

지방유래 줄기세포 시장-경쟁 구도 :

지방유래 줄기세포(ADSC) 시장 경쟁 구도은 다양한 의료 분야에서 ADSC의 치료 효과에 대한 인식 증가에 의해 형성됩니다. 각 기업은 연구 및 임상 분야에서 ADSC를 분리, 확장 및 응용할 수 있는 독자적인 제품과 기술을 개발하여 타사와 차별화하고 있습니다. 또한 새로운 지역에 진출하거나 판매업체와 제휴하고, 재생 미용과 수의학 등 신흥 분야에 주력함으로써 ADSC 시장에서의 도달범위를 넓히려 하고 있습니다. 시장 확대 전략으로는 규제 당국의 승인 취득, 시장 진입 이니셔티브의 개시, 헬스 케어 산업의 유력자와 전략적 파트너십 형성 등이 있습니다.

목차

제1장 지방유래 줄기세포 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 지방유래 줄기세포의 주요 시장 동향

  • 지방유래 줄기세포 시장 성장 촉진요인
  • 지방유래 줄기세포 시장 성장 억제요인
  • 지방유래 줄기세포 시장 기회
  • 지방유래 줄기세포 시장의 향후 동향

제4장 지방유래 줄기세포의 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 프레임워크 분석

제5장 지방유래 줄기세포 시장 : COVID-19 영향 분석

  • COVID-19 이전 영향 분석
  • COVID-19 이후 영향 분석

제6장 지방유래 줄기세포 시장 상황

  • 지방유래 줄기세포 시장 점유율 분석(2023년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 지방유래 줄기세포 시장-유형별

  • 개요
    • 부문 점유율 분석, 유형별
    • 자가 줄기 세포
    • 동종 줄기세포

제8장 지방유래 줄기세포 시장-제품별

  • 개요
    • 부문 점유율 분석, 제품별
    • 세포주
    • 배양액
    • 배지
    • 혈청
    • 시약

제9장 지방유래 줄기세포 시장-질환별

  • 개요
    • 부문 점유율 분석, 질병별
    • 암
    • 비만
    • 상처 및 부상
    • 근골격계 질환
    • 심혈관 질환
    • 중추 신경계 질환
    • 대사성 질환
    • 위장질환
    • 기타

제10장 지방유래 줄기세포 시장-최종 사용자별

  • 개요
    • 부문 점유율 분석, 최종 사용자별
    • 세포 은행·조직 은행
    • 연구실·학술 기관
    • 병원·외상 센터
    • 기타

제11장 지방유래 줄기세포 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 남미
    • 개요
    • 남미의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석-지방유래 줄기세포 산업

  • 경쟁 대시보드
  • 기업 프로파일
    • AlloCure
    • Antria
    • Celgene Corporation
    • Cellleris
    • Corestem
    • Cytori Therapeutics
    • Intrexon
    • Mesoblast
    • Pluristem Therapeutics
    • Tissue Genesis
    • BioRestorative Therapies
    • Celltex Therapeutics Corporation
    • iXCells Biotechnologies
    • Cyagen
    • Lonza
    • Others

제13장 애널리스트의 전방위 전망

LYJ

REPORT HIGHLIGHT

Adipose Derived Stem Cell Market size was valued at USD 2,144.5 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

Adipose-derived stem cells (ADSCs) possess the ability to sustain self-renewal and exhibit an enhanced potential for multiple types of differentiation. This is achieved through the secretion of diverse paracrine factors and extracellular vesicles, enabling them to effectively restore impaired organs and tissues. As a result, there has been a growing focus on utilizing ADSCs in the fields of tissue engineering and organ regeneration. Obtaining ADSCs in substantial quantities is relatively straightforward, as they can be acquired through minimally invasive techniques like liposuction. This accessibility renders them an appealing source for applications in regenerative medicine and tissue engineering. Extensive research has been conducted to explore their therapeutic potential in addressing various medical conditions, including tissue repair, wound healing, and the regeneration of damaged or diseased tissues.

Adipose Derived Stem Cell Market- Market Dynamics

Rising demand for minimally invasive cosmetic procedures is anticipated to fuel market growth

Liposuction, which is a commonly used procedure for harvesting adipose tissue for ADSC isolation, is contributing to the availability of adipose tissue for ADSC-based therapies. The American Society of Plastic Surgeons (ASPS) reported that nearly 18 million individuals underwent surgical and minimally invasive cosmetic procedures in the United States in 2018, indicating a rising trend. This growth in the market is also creating opportunities for companies to commercialize ADSC-based products and therapies. However, it is important to note that safety concerns may pose restrictions on the market's expansion.

Adipose Derived Stem Cell Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on Type segmentation, Allogeneic Stem Cells were predicted to show maximum market share in the year 2023

Based on region, North America was the leading revenue generator in 2023

Adipose Derived Stem Cell Market- Segmentation Analysis:

The Global Adipose Derived Stem Cell Market is segmented based on Type, Product Type, Disease, Technology and Region.

The market is categorized into two groups according to Type: Autologous Stem Cells and Allogeneic Stem Cells. Allogeneic Stem Cells hold the majority share in the market. The combination of adipose-derived stem cells and allogeneic stem cells is a significant field of study and advancement in regenerative medicine. These sources of stem cells provide distinct benefits and are currently under investigation for their potential in treating various diseases and medical conditions.

The market is segmented into four groups according to Product Type: Cell line, Culture media, Media, Sera, and Reagents. The market for adipose-derived stem cells includes a wide range of products, such as cell lines, culture media, sera, and reagents, all of which are essential for driving progress in research, development, and commercialization within the regenerative medicine sector.

The market is segmented into eight categories according to Disease: Cancer, Obesity, Wounds and Injuries, Musculoskeletal Diseases, Cardiovascular Diseases, Central Nervous System Diseases, Metabolic Diseases, Gastro-intestinal Diseases, and Other conditions. Adipose-derived stem cells are highly versatile and possess regenerative capabilities, positioning them as promising candidates for innovative therapies in a wide range of medical fields.

The market is categorized into three groups based on End-User: Cell banks & tissue banks, Research laboratories and Academic institutes, Hospitals and Trauma centers and Others. It is imperative for collaboration and interdisciplinary efforts among these stakeholders to drive advancements in the field of regenerative medicine and facilitate the translation of ADSC-based therapies into clinical practice.

Adipose Derived Stem Cell Market- Geographical Insights

Geographically, this market is extensively spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The market is predominantly dominated by North America, primarily due to the growing number of research and development initiatives undertaken by various organizations. Notably, government agencies in North America, such as the National Institutes of Health (NIH) in the U.S., play a significant role by providing substantial funding for stem cell research. This financial support greatly accelerates research and development efforts, fosters innovation, and contributes to advancements in understanding ADSC biology and therapeutic applications. In 2019, the United States witnessed a remarkable research and experimental development (R&D) performance, reaching USD 667 billion, and it is estimated to have further increased to USD 708 billion in 2020, as reported by the National Science Foundation. Europe holds the second-largest region for market growth, primarily driven by the increasing consumer awareness of regenerative medicine.

Adipose Derived Stem Cell Market- Competitive Landscape:

The competitive landscape of the market for adipose-derived stem cells (ADSC) is shaped by the growing awareness of the therapeutic benefits of ADSCs in different medical fields. Businesses aim to set themselves apart by creating unique products and technologies for the isolation, expansion, and application of ADSCs in both research and clinical settings. They are also looking to broaden their reach in the ADSC market by venturing into new regions, forming partnerships with distributors, and focusing on emerging areas like regenerative aesthetics and veterinary medicine. Strategies for market expansion may involve obtaining regulatory approvals, launching market access initiatives, and forming strategic partnerships with influential figures in the healthcare industry.

Recent Developments:

In October 2023, as per Takeda's announcement, the Phase 3 ADMIRE-CD II research, which evaluated the safety and effectiveness of Alofisel(R) (darvadstrocel) in treating complex Crohn's Perianal Fistulas (CPF), failed to achieve its primary goal of combined remission at 24 weeks, according to topline results. Nothing new was found in terms of safety signals, and darvadstrocel's safety profile matched that of earlier research.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Adipose Derived Stem Cell MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AlloCure

Antria

Celgene Corporation

Cellleris

Corestem

Cytori Therapeutics

Intrexon

Mesoblast

Pluristem Therapeutics

Tissue Genesis

BioRestorative Therapies

Celltex Therapeutics Corporation

iXCells Biotechnologies

Cyagen

Lonza

Others

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Stem Cells
  • Allogeneic Stem Cells

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cell line
  • Culture media
  • Media
  • Sera
  • Reagents

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Obesity
  • Wounds and Injuries
  • Musculoskeletal Diseases
  • Cardiovascular Diseases
  • Central Nervous System Diseases
  • Metabolic Diseases
  • Gastro-intestinal Diseases
  • Others

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Cell banks & tissue banks
  • Research laboratories and Academic institutes
  • Hospitals and Trauma centers
  • Other

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Adipose Derived Stem CellMarket Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Adipose Derived Stem CellMarket Snippet by Type
    • 2.1.2.Adipose Derived Stem CellMarket Snippet by Product Type
    • 2.1.3.Adipose Derived Stem CellMarket Snippet by Disease
    • 2.1.4.Adipose Derived Stem CellMarket Snippet by End-User
    • 2.1.5.Adipose Derived Stem CellMarket Snippet by Country
    • 2.1.6.Adipose Derived Stem CellMarket Snippet by Region
  • 2.2.Competitive Insights

3.Adipose Derived Stem CellKey Market Trends

  • 3.1.Adipose Derived Stem CellMarket Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Adipose Derived Stem CellMarket Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Adipose Derived Stem CellMarket Opportunities
  • 3.4.Adipose Derived Stem CellMarket Future Trends

4.Adipose Derived Stem CellIndustry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Adipose Derived Stem CellMarket: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Adipose Derived Stem CellMarket Landscape

  • 6.1.Adipose Derived Stem CellMarket Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Adipose Derived Stem CellMarket - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Autologous Stem Cells
    • 7.1.3.Allogeneic Stem Cells

8.Adipose Derived Stem CellMarket - By Product Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 8.1.2.Cell line
    • 8.1.3.Culture media
    • 8.1.4.Media
    • 8.1.5.Sera
    • 8.1.6.Reagents

9.Adipose Derived Stem CellMarket - By Disease

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 9.1.2.Cancer
    • 9.1.3.Obesity
    • 9.1.4.Wounds and Injuries
    • 9.1.5.Musculoskeletal Diseases
    • 9.1.6.Cardiovascular Diseases
    • 9.1.7.Central Nervous System Diseases
    • 9.1.8.Metabolic Diseases
    • 9.1.9.Gastro-intestinal Diseases
    • 9.1.10.Others

10.Adipose Derived Stem CellMarket - By End-User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2.Cell banks & tissue banks
    • 10.1.3.Research laboratories and Academic institutes
    • 10.1.4.Hospitals and Trauma centers
    • 10.1.5.Other

11.Adipose Derived Stem CellMarket- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Adipose Derived Stem CellKey Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Adipose Derived Stem CellKey Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Adipose Derived Stem CellKey Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Adipose Derived Stem CellKey Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Adipose Derived Stem CellKey Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Adipose Derived Stem CellIndustry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.AlloCure
    • 12.2.2.Antria
    • 12.2.3.Celgene Corporation
    • 12.2.4.Cellleris
    • 12.2.5.Corestem
    • 12.2.6.Cytori Therapeutics
    • 12.2.7.Intrexon
    • 12.2.8.Mesoblast
    • 12.2.9.Pluristem Therapeutics
    • 12.2.10.Tissue Genesis
    • 12.2.11.BioRestorative Therapies
    • 12.2.12.Celltex Therapeutics Corporation
    • 12.2.13.iXCells Biotechnologies
    • 12.2.14.Cyagen
    • 12.2.15.Lonza
    • 12.2.16.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제